Gainers

• Milestone Scientific (AMEX:MLSS) shares rose 34.4% to $0.33 during Monday's pre-market session. The market value of their outstanding shares is at $19.3 million.
• BGM Group (NASDAQ:BGM) shares rose 30.44% to $0.78. The market value of their outstanding shares is at $120.3 million.
• Zhengye Biotechnology (NASDAQ:ZYBT) stock increased by 26.76% to $0.9. The market value of their outstanding shares is at $33.6 million.
• Firefly Neuroscience (NASDAQ:AIFF) shares rose 23.52% to $1.89. The market value of their outstanding shares is at $24.0 million.
• Apogee Therapeutics (NASDAQ:APGE) shares moved upwards by 13.56% to $75.0. The market value of their outstanding shares is at $4.5 billion.
• Insmed (NASDAQ:INSM) stock increased by 10.25% to $149.95. The company's market cap stands at $29.3 billion.

Losers

• Valneva (NASDAQ:VALN) stock decreased by 36.8% to $6.52 during Monday's pre-market session. The company's market cap stands at $896.5 million. As per the press release, Q4 earnings came out 3 days ago.
• Impact BioMedical (AMEX:IBO) shares decreased by 23.04% to $0.6. The company's market cap stands at $84.1 million.
• Onconetix (NASDAQ:ONCO) stock fell 17.75% to $0.51.
• Anika Therapeutics (NASDAQ:ANIK) shares declined by 16.48% to $11.57. The company's market cap stands at $199.6 million.
• NeuroPace (NASDAQ:NPCE) shares decreased by 15.39% to $11.0. The company's market cap stands at $433.0 million.
• CDT Equity (NASDAQ:CDT) shares fell 10.65% to $0.43. The company's market cap stands at $1.1 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.